Navigation Links
Trans fatty acids increase the risk of gallstone disease

Several studies have shown that consumption of trans fatty acids leads to development of diabetes//, cancer and cardiovascular disease. Trans fatty acids are the hydrogenated and partially hydrogenated oil present in some margarines, candies, baked goods and many processed foods. They are produced commercially in large quantities by heating vegetable oils in the presence of metal catalysts and in the process the poly unsaturated fatty acids are removed. Trans fatty acids increase LDL cholesterol (the bad cholesterol) and decrease HDL cholesterol (the good cholesterol)thereby increasing the risk of heart disease.

A prospective study published in the May issue of the Archives of Internal Medicine has shown that higher consumption of trans fatty acids increased the risk of gallstone disease. The study was performed by applying a semi quantitative questionnaire that had questions relating to the food and frequency of food intake to a cohort of nearly 46000 men twice a year. Patients diagnosed with gallstone disease based on the X ray and cholecystectomy findings were recorded. During 14 years of follow-up, 2356 new cases of patients with symptoms who had gallstones were recorded. The result which was adjusted for difference in age and other associated risk factors showed that those men who had taken higher amounts trans fatty acids had a greater relative risk(1.23) of gallstone diseases compared with those who had taken lower amounts. Among the subtypes of trans fatty acids risk was more with trans-oleic fatty acid as compared to the other types.

Intake of the unsaturated vegetable oils from canola, peanuts, olive, flax, corn, safflower and sunflower which contain monounsaturated or polyunsaturated fatty acids that can reduce total cholesterol and increase HDL cholesterol levels assumes significant importance in this context. So play it safe by eating safe.

Reference : Arch Intern Med. 2005;165:997-1003.
'"/>




Page: 1

Related medicine news :

1. Transdermal HRT not cardioprotective in postmenopausal women with CAD
2. Transdermal HRT not cardioprotective in postmenopausal women with Coronary Artery Disease
3. Stem Cell Transplants May Be Effective For MS Patients
4. Transforming stem cells to lung cells
5. Alternative to blood Transfusions
6. Need for Blood Transfusions reduced
7. Drugs Deter Heart Disease for Transplant Patients
8. Better Drug for Heart Transplant
9. Kidney Failure after Non-Kidney Transplants
10. Measles Risk in Transplant Patients
11. West Nile and Blood Transfusions
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Trans fatty acids increase the risk gallstone disease

(Date:8/27/2014)... The American College of ... management and treatment of pulmonary arterial hypertension (PAH) ... in Adults: CHEST Guideline, in the journal CHEST. ... and provide the latest and most accurate treatment ... Association (PHA) – the country’s leading pulmonary ...
(Date:8/27/2014)... HealthDay Reporter WEDNESDAY, Aug. 27, 2014 (HealthDay ... alley will likely never want to return there, having associated ... neuroscientists working with mice say they,ve discovered the brain circuit ... emotions. And in rodent tests, they,ve manipulated brain cells to ... they made once-reluctant mice want to return to that dark ...
(Date:8/27/2014)... MI (PRWEB) August 27, 2014 Michigan Head ... help the children of a local elementary school by ensuring ... Siersma Elementary School has year-round attendance, and Michigan Head & ... to meet the new school year. , "There are a ... this is a great way to give back to our ...
(Date:8/27/2014)... The federal judge overseeing thousands of ... the deadline for plaintiffs to enroll in the U.S. ... by U.S. District Judge David Katz of the Northern ... DePuy ASR Settlement Program must do so by September ... Implant Products Liability Litigation – MDL 2197) , “Our ...
(Date:8/27/2014)... News) -- Pouring half a glass of wine at a time ... study. Researchers asked 74 college students and staff to pour ... had varying amounts of wine in them. The participants were told ... a "rule of thumb" about how much to pour -- such ... the top -- poured less wine than those without set guidelines. ...
Breaking Medicine News(10 mins):Health News:Pulmonary Hypertension Association Endorses CHEST Guidelines for Treatment of Pulmonary Arterial Hypertension in Adults 2Health News:Scientists 'Rewrite' Bad Memories in Mice 2Health News:Scientists 'Rewrite' Bad Memories in Mice 3Health News:Michigan Head & Neck Institute is Conducting Their 2nd Annual School Supplies Drive at Their Facility to Benefit Local Year-Round Elementary School Students 2Health News:DePuy ASR Settlement Enrollment Deadline Extended Until September 30, 2014, Bernstein Liebhard LLP Reports 2Health News:DePuy ASR Settlement Enrollment Deadline Extended Until September 30, 2014, Bernstein Liebhard LLP Reports 3Health News:'Half a Glass' Rule May Curb Overdrinking 2
... Center,s Average ER Wait TimePANAMA CITY, Fla., May 21 ... area to find out the average ER wait time at ... The hospital is posting its average ER wait times ... became the only hospital in our area to post our ...
... opened door to NUHW organizing effortOAKLAND, Calif., May 21 ... the recent decision by the California Public Employee Relations ... Medical Center (DMC) in San Pablo to continue. The ... violations of labor law by DMC management and organizers ...
... span in mice may hold hope for people, , , THURSDAY, ... discovered a way to boost chemotherapy and slightly extend the ... for more effective treatments in people. , There,s no guarantee ... it did, the researchers don,t expect that it would add ...
... and Financing Offerings Help Healthcare Providers to Accelerate ... May 21 Perot Systems Corporation (NYSE: ... today announced the availability of financing options to ... implementation of electronic health records which are being ...
... Committee, the region,s most prominent business organization, today applauded ... Board report in Atlanta, Georgia. Greater Baltimore Committee ... Board process has been of great value to the ... is appreciated by the business community. He is ...
... health and economic data like you,ve never seen it ... Hans Rosling will show how reproductive health ... will also illustrate how the convergence of conditions around ... "Western" and "developing" categories an outdated concept.On Tuesday, ...
Cached Medicine News:Health News:ER Wait Times at Your Fingertips 2Health News:Doctors Medical Center Election Tainted 2Health News:A New Way to Get Chemo to Pancreatic Tumors 2Health News:Perot Systems Announces Special Financing Options for Stimulus Plan Healthcare Technology Upgrades 2Health News:Perot Systems Announces Special Financing Options for Stimulus Plan Healthcare Technology Upgrades 3Health News:Gapminder's Hans Rosling Brings Poverty, Health Data to Life at Wilson Center 2
(Date:8/27/2014)... 2014 North American lighting leader OSRAM SYLVANIA ... for the new OSRAM ITOS ® PHASER ® ... for microscopy, endoscopy and surgical head lamps that delivers the ... and lamp life. "We,re honored to be recognized ... innovative new technologies of the past year," said Andreas ...
(Date:8/27/2014)... 27, 2014  Columbia Laboratories, Inc. (Nasdaq: ... pharmaceutical development, clinical trial manufacturing, and advanced analytical and ... it will participate at the upcoming Rodman & Renshaw ... held in New York . The ... September 9, 2014 at the New York Palace Hotel. ...
(Date:8/27/2014)... /CNW/ - Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: ... results for its third quarter of fiscal 2014: ... , Revenue of $1,291,378, a 13% decrease over the same ... the quarter of $240,156 compared to net income of $238,826 ... For the nine months ended June 30, 2014: ...
Breaking Medicine Technology:OSRAM ITOS PHASER 3000 Laser and LED Light Module Recognized With Prestigious R&D 100 Award 2OSRAM ITOS PHASER 3000 Laser and LED Light Module Recognized With Prestigious R&D 100 Award 3Covalon Announces Third Quarter Results 2Covalon Announces Third Quarter Results 3
... March 8, 2011 BioMarin Pharmaceutical Inc. (Nasdaq: ... of BioMarin, will present a company update at the Barclays ... at 4:15 p.m. ET.   Interested parties may ... the investor section of the BioMarin website, www.BMRN.com . ...
... (Nasdaq: VRML ) –Vermillion, a molecular ... data from its collaboration with Johns Hopkins University School ... specificity of CA125 for the identification of malignant ovarian ... Meeting on Women,s Cancer of the Society of Gynecologic ...
Cached Medicine Technology:BioMarin to Present at the Barclays Global Healthcare Conference 2Vermillion Announces Presentation of Positive Ovarian Biomarker Data for Next Generation Test 2Vermillion Announces Presentation of Positive Ovarian Biomarker Data for Next Generation Test 3
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Medicine Products: